Stoke Therapeutics, Inc. · NASDAQ:STOK

Montrago Trustees Ltd reported a 7.20% stake in Stoke Therapeutics, Inc. (Schedule 13D/A)

Event Jun 4, 2025 · Filed Jun 6, 2025

Montrago Trustees Ltd reported a 7.20% stake in Stoke Therapeutics, Inc., 3,906,181 shares, with active intent on Jun 4, 2025. Filed Jun 6, 2025 (Schedule 13D/A).

Stake
7.20%
Shares
3,906,181
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Blue Horizon Enterprise Ltd5.40%2,967,621
Ezbon International Ltd1.70%938,560
Montrago Trustees Ltd7.20%3,906,181
Skorpios Trust7.20%3,906,181

Source

View original at SEC

Related